Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dustin B Hammers

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 1, 2023
Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's diseaseJustin Bushnell, Dustin B Hammers, Paul Aisen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 6, 2026
Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADSDustin B Hammers, Angelina Polsinelli, Ani Eloyan, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Development and validation of a harmonized memory score for multicenter Alzheimer's disease and related dementia researchMark Sanderson-Cimino, Alden L Gross, Leslie S Gaynor, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2025
Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohortsYuta Katsumi, Alexandra Touroutoglou, Michael Brickhouse, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 31, 2023
Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collectionDustin B Hammers, Ani Eloyan, Alexander Taurone, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2023
Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease StudyJeffrey L Dage, Ani Eloyan, Maryanne Thangarajah, et al.
Brain Communications|June 8, 2026
Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's diseaseMarlene Lin, Konstantinos Chiotis, Piyush Maiti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2023
Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS)Hanna Cho, Nidhi S Mundada, Liana G Apostolova, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 27, 2023
Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's diseaseSára Nemes, Paige E Logan, Mohit K Manchella, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 9, 2023
Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohortAngelina J Polsinelli, Ryan J Wonderlin, Dustin B Hammers, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 1, 2023
Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's diseaseJustin Bushnell, Dustin B Hammers, Paul Aisen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 6, 2026
Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADSDustin B Hammers, Angelina Polsinelli, Ani Eloyan, et al.
Medrxiv : the Preprint Server for Health Sciences|April 16, 2025
Development and validation of a harmonized memory score for multicenter Alzheimer's disease and related dementia researchMark Sanderson-Cimino, Alden L Gross, Leslie S Gaynor, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2025
Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohortsYuta Katsumi, Alexandra Touroutoglou, Michael Brickhouse, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 31, 2023
Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collectionDustin B Hammers, Ani Eloyan, Alexander Taurone, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2023
Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease StudyJeffrey L Dage, Ani Eloyan, Maryanne Thangarajah, et al.
Brain Communications|June 8, 2026
Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's diseaseMarlene Lin, Konstantinos Chiotis, Piyush Maiti, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2023
Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS)Hanna Cho, Nidhi S Mundada, Liana G Apostolova, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 27, 2023
Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's diseaseSára Nemes, Paige E Logan, Mohit K Manchella, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 9, 2023
Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohortAngelina J Polsinelli, Ryan J Wonderlin, Dustin B Hammers, et al.
Pageof 10